2238 Martinez-Outshoorn, Ubaldo - Thomas Jefferson University - Thomas Jefferson University
Dr. Martinez-Outshoorn

Ubaldo Martinez-Outshoorn, MD

Contact Dr. Martinez-Outshoorn

925 Chestnut Street
Suite 220A
Philadelphia, PA 19107

(215) 955-8874

Most Recent Peer-reviewed Publications

  1. A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation
  2. Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease
  3. Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells
  4. Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling
  5. Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells
  6. Multicompartment metabolism in papillary thyroid cancer
  7. Caveolae and signalling in cancer
  8. A two-step approach to myeloablative haploidentical transplantation: Low nonrelapse mortality and high survival confirmed in patients with earlier stage disease
  9. Targeting tumor-initiating cells: Eliminating anabolic cancer stem cells with inhibitors of protein synthesis or by mimicking caloric restriction
  10. Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy
  11. Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
  12. JNK1 stress signaling is hyper-activated in high breast density and the tumor stroma: Connecting fibrosis, inflammation, and stemness for cancer prevention
  13. Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth
  14. The reverse warburg effect in osteosarcoma
  15. Tumor microenvironment: Introduction
  16. Tumor microenvironment and metabolic synergy in breast cancers: Critical 0778 importance of mitochondrial fuels and function
  17. Cancer metabolism: New validated targets for drug discovery
  18. Stromal glycolysis and MCT4 are hallmarks of DCIS progression to invasive breast cancer
  19. Oncogenes induce the cancer-associated fibroblast phenotype: Metabolic symbiosis and "fibroblast addiction" are new therapeutic targets for drug discovery
  20. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment RAS and NFκB target stromal MCT4
0